Research Radartracking 4 published studies · 1 human · 2 clinical trials · 2 cancer pages · updated Jun 2026Open the Research Map →

Brazil Nuts / Selenium

Selenium-rich Brazil nuts upregulate antioxidants GPx/TrxR, promote apoptosis; mixed oncology data but strong for Se status improvement.

← All agents

Human-reviewed · How we review →

AI extractedhuman reviewedsources checkedretractions suppressed

🏥⭐⭐⭐⭐ Strong — Human RCTs show Brazil nuts elevate Se and GPx; oncology prevention/therapy data are mixed and status-dependent.Selenium-rich nutsBertholletia excelsa nuts

Forms: Whole Brazil nuts (1–3 nuts per day)

Educational only, not medical advice. OncoForge makes no claim that Brazil Nuts / Selenium treats, prevents, or cures any condition, beyond what the linked studies show. Evidence levels vary; effects may not translate to people, and some compounds can cause harm. Always coordinate with your oncology team.

Simple Summary

Brazil nuts raise selenium and boost antioxidant enzymes (GPx, TrxR) in humans; selenium metabolites can trigger tumor-cell apoptosis in models. Benefits are dose- and baseline-dependent, and prevention trials are mixed. Use within a safe window to avoid selenosis.

Evidence at a glance

Tier 4 · clinicalProstateSkinBreast (preclinical)Various

Strong — RCTs for Se status/antioxidants; mixed for oncology prevention/therapy, status-dependent.

How it may work

Selenium, abundant in Brazil nuts, upregulates selenoproteins like glutathione peroxidase (GPx) and thioredoxin reductase (TrxR), reducing oxidative stress and neutralizing free radicals. Methylselenol, a selenium metabolite, triggers p53-mediated apoptosis and inhibits tumor progression. Selenium status also shapes immune function, enhancing NK- and T-cell activity in supplementation studies. Selenium is central to the GPX4 pathway that suppresses ferroptosis; selenium deprivation can induce ferroptosis, a mechanism relevant to tumor progression and metastasis biology.

Targets & pathways

Curated mechanistic targets reported for this agent — how it may act on cells, not proof of a clinical effect.

  • Glutathione Peroxidase (GPx)Enhances antioxidant defense
  • Thioredoxin Reductase (TrxR)
  • Apoptosisp53-mediated via methylselenol
  • Oxidative Stress
  • Immune Function (NK/T-cells)
  • Ferroptosis SuppressionVia GPX4; deprivation induces ferroptosis
GPxTrxRApoptosis

Often studied / combined with

Combinations reported in the literature, not a protocol or a recommendation.

Overlapping mechanisms

Safety & interactions

Severity and how well-established each signal is are shown separately. Verify everything with your oncologist or pharmacist — absence here does not mean safe.

Risk categories
Selenosis RiskDiabetes Risk MildSkin Cancer RiskPregnancy Monitor
Potential interactions
  • Antidiabetic medicationsMonitorMinorTheoreticalMay affect blood sugar; potential diabetes risk.
  • AnticoagulantsMonitorMinorTheoreticalPossible interaction with selenium.
  • Chemotherapy / RadiationConsiderBeneficialTheoreticalMay reduce side effects, enhance efficacy; preclinical synergies.

Timing

References

Research

No published studies for Brazil Nuts / Selenium yet

New studies appear here once they’ve been reviewed. Browse all studies.

Dose: as studied, not a recommendation

These are doses as studied or reported, never a recommendation. The right amount of Brazil Nuts / Selenium depends on you, your other medicines, and your situation; decide it with your oncology team and pharmacist, not from a web page.

Ranges seen in adjunct / practice use: 50–400 μg (po) Daily selenium intake from 1–4 Brazil nuts (average 50–300 μg Se, depending on nut content ~50–100 μg/nut). For cancer prevention/adjunct, aim for 200 μg/day (~2–3 nuts) based on trials like SELECT; total intake not exceeding 400 μg to avoid toxicity., No Rx required. Se content varies by soil; test blood Se if possible. Oncology use supportive for low-Se individuals—consult clinician..

Trials studying Brazil Nuts / Selenium

No actively-recruiting trials matched right now. Recruiting is not the same as proven. Search ClinicalTrials.gov →

Inclusion here is not an endorsement. OncoForge makes no claim beyond what the linked studies show. Discuss anything on this page with your oncology team before acting on it.

← All agents · Research Radar